BGLC VS AFIB Stock Comparison

PerformanceProfitVolatilityTechnicalsEarnings
PerformanceProfitVolatilityTechnicalsEarnings

Performance

BGLC
10/100

BGLC returned -97.12% in the last 12 months. Based on SPY's performance of -13.73%, its performance is below average giving it a score of 10 of 100.

AFIB
10/100

AFIB returned -74.93% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Profit

BGLC
33/100

Out of the last 18 quarters, BGLC has had 6 profitable quarters and has increased their profits year over year on 4 of them.

AFIB
13/100

Out of the last 19 quarters, AFIB has had 2 profitable quarters and has increased their profits year over year on 2 of them.

Volatility

BGLC
56/100

BGLC has had a higher than average amount of volatility over the last 12 months giving it a score of 56 of 100.

AFIB
30/100

AFIB has had a lower than average amount of volatility over the last 12 months giving it a score of 30 of 100.

Technicals

BGLC

"Technicals" not found for BGLC

AFIB
14/100

AFIB receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

Earnings

BGLC

"Earnings" not found for BGLC

AFIB
10/100

AFIB has missed earnings 7 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

BioNexus Gene Lab Corp Common stock Summary

Nasdaq / BGLC
Healthcare
Medical - Diagnostics & Research
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Acutus Medical, Inc. Common Stock Summary

Nasdaq / AFIB
Healthcare
Medical - Devices
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.